Ruxolitinib for myelofibrosis: from 'palliation' to prolongation of survival.

Oncology (Williston Park, N.Y.)

PubMedID: 23977769

Verstovsek S. Ruxolitinib for myelofibrosis: from 'palliation' to prolongation of survival. Oncology (Williston Park, NY). 2013;27(7):717-8.
An abstract is not available. Please access the article through the links below.